| Name | Title | Contact Details |
|---|
MEDHOST is a provider of market-leading enterprise, departmental and healthcare engagement solutions to more than 1,100 healthcare facilities. Our integrated product portfolio includes intuitive, cloud-based solutions, including YourCareEverywhere, a robust health and wellness consumer engagement platform. Our broad offering of hosting, outsourcing, marketing and consulting services are changing how clinicians and hospital leaders work and collaborate, while generating notable operational improvements. MEDHOST delivers value by enabling hospitals of all types and all sizes to better manage the business of healthcare across the care continuum while meeting evolving regulatory requirements.
Dilon Diagnostics is a Newport News, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
M*Modal offers a new breed of speech understanding applications. Our hosted conversational documentation services help healthcare providers capture clinical information from dictation and transform it directly into accessible, retrievable, and shareable electronic files. M*Modal serves hospitals, medical clinics, and medical transcription companies representing a transaction volume of more than 400 million dictation minutes a year.
Acumed Medical is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific`s Reveal™ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specific`s unique patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specific`s system streamlines lab workflow, reduce costs, and substantially shorten the time from sample arrival to selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections. Specific and its founders have written almost 60 peer-reviewed publications, detailing the successful demonstration of the SMS array technology. The Company itself has independently authored over 20 scientific publications and conference abstracts detailing the SMS array powered detection, identification and antibiotic susceptibility testing.